{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T16:29:19Z","timestamp":1770481759629,"version":"3.49.0"},"reference-count":107,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2009,2,1]],"date-time":"2009-02-01T00:00:00Z","timestamp":1233446400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Best Practice &amp; Research Clinical Obstetrics &amp; Gynaecology"],"published-print":{"date-parts":[[2009,2]]},"DOI":"10.1016\/j.bpobgyn.2008.10.005","type":"journal-article","created":{"date-parts":[[2008,12,3]],"date-time":"2008-12-03T18:58:23Z","timestamp":1228330703000},"page":"87-107","source":"Crossref","is-referenced-by-count":9,"title":["Cancer issues"],"prefix":"10.1016","volume":"23","author":[{"given":"Jo","family":"Marsden","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Sturdee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bpobgyn.2008.10.005_bib2","doi-asserted-by":"crossref","first-page":"113","DOI":"10.2325\/jbcs.966","article-title":"Optimizing the antihormonal treatment and prevention of breast cancer","volume":"14","author":"Patel","year":"2007","journal-title":"Breast Cancer"},{"key":"10.1016\/j.bpobgyn.2008.10.005_bib3","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1093\/humupd\/dmi028","article-title":"Breast cancer risk with postmenopausal hormonal treatment","volume":"11","author":"Collins","year":"2005","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.bpobgyn.2008.10.005_bib4","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/S0140-6736(97)08233-0","article-title":"Breast cancer and hormone replacement therapy: collaborative reanalysis from 51 individual epidemiological studies","volume":"350","author":"Collaborative Group on Hormonal Factors for Breast Cancer","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.bpobgyn.2008.10.005_bib5","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial","volume":"288","author":"Rossouw","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.bpobgyn.2008.10.005_bib6","doi-asserted-by":"crossref","first-page":"3243","DOI":"10.1001\/jama.289.24.3243","article-title":"for the Women's Health Initiative Randomised Trial. Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women","volume":"289","author":"Chlebowski","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.bpobgyn.2008.10.005_bib7","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.maturitas.2006.05.004","article-title":"Prior hormone therapy and breast cancer risk in the Women's Health Initiative randomized trial of estrogen plus progestin","volume":"55","author":"Anderson","year":"2006","journal-title":"Maturitas"},{"key":"10.1016\/j.bpobgyn.2008.10.005_bib8","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1001\/jama.291.14.1701","article-title":"Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial","volume":"291","author":"Anderson","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.bpobgyn.2008.10.005_bib9","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1001\/jama.295.14.1647","article-title":"Effects of conjugated equine estrogens on breast cancer and mammography screening in postmenopausal women with hysterectomy","volume":"295","author":"Stefanick","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.bpobgyn.2008.10.005_bib10","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s10549-007-9523-x","article-title":"Unequal risks for breast cancer associated with different hormone replacement therapies: results from the E3N cohort study","volume":"107","author":"Fournier","year":"2008","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.bpobgyn.2008.10.005_bib11","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0140-6736(03)14065-2","article-title":"Breast cancer and hormone-replacement therapy in the Million Women Study","volume":"362","author":"Million Women Study Collaborators","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.bpobgyn.2008.10.005_bib12","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/j.1471-0528.2002.01167.x","article-title":"Intrauterine 10 microg and 20 microg levonorgestrel systems in postmenopausal women receiving oral oestrogen replacement therapy: clinical, endometrial and metabolic response","volume":"109","author":"Raudaskoski","year":"2002","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.bpobgyn.2008.10.005_bib13","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1097\/01.gme.0000247013.62092.1c","article-title":"Levonorgestrel-releasing intrauterine system as an adjunct to estrogen for the treatment of menopausal symptoms \u2013 a review","volume":"14","author":"Peled","year":"2007","journal-title":"Menopause"},{"key":"10.1016\/j.bpobgyn.2008.10.005_bib14","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1097\/01.AOG.0000178754.88912.b9","article-title":"Use of the levonorgestrel-releasing intrauterine system and breast cancer","volume":"106","author":"Backman","year":"2005","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2008.10.005_bib15","article-title":"Use of the levonorgestrel-releasing intrauterine system in breast cancer patients","author":"Trinh","year":"2007","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2008.10.005_bib16","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1056\/NEJMe058111","article-title":"Benign breast disease \u2013 the risks of communicating risk","volume":"353","author":"Elmore","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bpobgyn.2008.10.005_bib17","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1056\/NEJMra035692","article-title":"Benign breast disorders","volume":"353","author":"Santen","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bpobgyn.2008.10.005_bib18","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1093\/jnci\/djn075","article-title":"Conjugated equine estrogen and risk of benign proliferative breast disease: a randomized controlled trial","volume":"100","author":"Rohan","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.bpobgyn.2008.10.005_bib19","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1002\/(SICI)1097-0142(19990315)85:6<1277::AID-CNCR9>3.0.CO;2-E","article-title":"Estrogen replacement therapy in women with a history of proliferative breast disease","volume":"85","author":"Dupont","year":"1999","journal-title":"Cancer"},{"key":"10.1016\/j.bpobgyn.2008.10.005_bib20","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1002\/1097-0142(20001115)89:10<2046::AID-CNCR3>3.0.CO;2-F","article-title":"Biopsy confirmed benign breast disease, postmenopausal use of exogenous female hormones, and breast carcinoma risk","volume":"89","author":"Byrne","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.bpobgyn.2008.10.005_bib22","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/GCO.0b013e32801195da","article-title":"Prophylactic oophorectomy in women at increased cancer risk","volume":"19","author":"Domchek","year":"2007","journal-title":"Curr Opin Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2008.10.005_bib23","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/S0015-0282(99)00510-5","article-title":"Are randomised trials of hormone replacement therapy in symptomatic breast cancer patients feasible?","volume":"73","author":"Marsden","year":"2000","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2008.10.005_bib24","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0140-6736(04)15493-7","article-title":"HABITS (hormonal replacement therapy after breast cancer \u2013 is it safe?), a randomised comparison: trial stopped","volume":"363","author":"Holmberg","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.bpobgyn.2008.10.005_bib25","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1093\/jnci\/dji071","article-title":"on behalf of the Stockholm Breast Cancer Study Group. Menopausal hormone therapy after breast cancer: the Stockholm randomised trial","volume":"97","author":"von Schoultz","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.bpobgyn.2008.10.005_bib26","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1093\/jnci\/djn058","article-title":"Increased risk of recurrence after hormone replacement therapy in breast cancer survivors","volume":"100","author":"Holmberg","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.bpobgyn.2008.10.005_bib27","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1186\/bcr1831","article-title":"Mammographic density. Potential mechanisms of breast cancer risk associated with mammographic density: hypotheses based on epidemiological evidence","volume":"10","author":"Martin","year":"2008","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.bpobgyn.2008.10.005_bib28","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1136\/jms.8.1.29","article-title":"Hormone replacement therapy and the sensitivity and specificity of breast cancer screening: a review","volume":"8","author":"Banks","year":"2001","journal-title":"J Med Screen"},{"key":"10.1016\/j.bpobgyn.2008.10.005_bib29","doi-asserted-by":"crossref","first-page":"262","DOI":"10.7326\/0003-4819-130-4_Part_1-199902160-00003","article-title":"Effects of estrogen and estrogen-progestin on mammographic parenchymal density. Postmenopausal Estrogen\/Progestin Interventions (PEPI) Investigators","volume":"130","author":"Greendale","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.bpobgyn.2008.10.005_bib30","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1093\/jnci\/dji279","article-title":"Mammogram Density Study Investigators. Estrogen-plus-progestin use and mammographic density in postmenopausal women: Women's Health Initiative randomized trial","volume":"97","author":"McTiernan","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.bpobgyn.2008.10.005_bib31","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1001\/archinternmed.2007.123","article-title":"Women's Health Initiative Investigators. Estrogen plus progestin and breast cancer detection by means of mammography and breast biopsy","volume":"168","author":"Chlebowski","year":"2008","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.bpobgyn.2008.10.005_bib32","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1093\/jnci\/95.6.429","article-title":"Frequency and predictive value of a mammographic recommendation for short-interval follow-up","volume":"95","author":"Yasmeen","year":"2003","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.bpobgyn.2008.10.005_bib33","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1148\/radiol.2383050852","article-title":"Screening mammography: do women prefer a higher recall rate given the possibility of earlier detection of cancer?","volume":"238","author":"Ganott","year":"2006","journal-title":"Radiology"},{"key":"10.1016\/j.bpobgyn.2008.10.005_bib34","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.breast.2004.08.018","article-title":"Use of hormone replacement therapy (HRT) and survival following breast cancer diagnosis","volume":"14","author":"Fletcher","year":"2005","journal-title":"Breast"},{"key":"10.1016\/j.bpobgyn.2008.10.005_bib35","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1023\/A:1020299707510","article-title":"Estrogen receptor breast cancer phenotypes in the surveillance, epidemiology, and end results database","volume":"76","author":"Anderson","year":"2002","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.bpobgyn.2008.10.005_bib36","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1677\/ERC-06-0060","article-title":"Increased incidence of lobular breast cancer in women treated with hormone replacement therapy: implications for diagnosis, surgical and medical treatment","volume":"14","author":"Biglia","year":"2007","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.bpobgyn.2008.10.005_bib37","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1783\/147118903101198042","article-title":"Progestogens and breast cancer risk: the role of hormonal contraceptives and hormone replacement therapy","volume":"4","author":"Marsden","year":"2003","journal-title":"J Fam Plann Reprod Health Care"},{"key":"10.1016\/j.bpobgyn.2008.10.005_bib38","series-title":"Hormones and cancer","first-page":"153","article-title":"The endometrium and hormone replacement therapy: risk of estrogen and endometrial cancer","author":"Wells","year":"1999"},{"key":"10.1016\/j.bpobgyn.2008.10.005_bib39","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1001\/jama.1996.03530290040035","article-title":"Effects of hormone replacement therapy on endometrial histology in postmenopausal women. The Postmenopausal Estrogen\/Progestin Interventions (PEPI) trial","volume":"275","author":"Writing Group for the PEPI Trial","year":"1996","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.bpobgyn.2008.10.005_bib40","article-title":"Hormone replacement therapy in postmenopausal women: endometrial hyperplasia and irregular bleeding","author":"Lethaby","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.bpobgyn.2008.10.005_bib41","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/S0015-0282(03)01167-1","article-title":"Endometrial effects of lower doses of conjugated equine estrogens and medroxyprogesterone acetate: 2-year substudy results","volume":"80","author":"Pickar","year":"2003","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2008.10.005_bib42","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1093\/jnci\/91.13.1131","article-title":"Risk of endometrial cancer following estrogen replacement with and without progestins","volume":"91","author":"Weiderpass","year":"1999","journal-title":"J Nat Cancer Inst"},{"key":"10.1016\/j.bpobgyn.2008.10.005_bib43","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1093\/oxfordjournals.aje.a113417","article-title":"A case-control study of cancer of the endometrium","volume":"116","author":"Kelsey","year":"1982","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.bpobgyn.2008.10.005_bib44","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJM197901043000103","article-title":"Endometrial cancer and estrogen use. Report of a large case control study","volume":"300","author":"Antunes","year":"1979","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bpobgyn.2008.10.005_bib45","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/bjc.1989.91","article-title":"Endometrial cancer and patterns of use of estrogen replacement therapy: a cohort study","volume":"59","author":"Paganini-Hill","year":"1989","journal-title":"Br J Cancer"},{"key":"10.1016\/j.bpobgyn.2008.10.005_bib46","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1097\/00000478-199909000-00014","article-title":"A multi-centric European study testing the reproducibility of the WHO classification of endometrial hyperplasias with a proposal of a simplified working classification for biopsy and curettage specimens","volume":"23","author":"Bergeron","year":"1999","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.bpobgyn.2008.10.005_bib47","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jmig.2006.08.007","article-title":"Resectoscopic surgery may be an alternative to hysterectomy in high risk women with atypical endometrial hyperplasia","volume":"14","author":"Edris","year":"2007","journal-title":"J Minim Invasive Gynecol"},{"key":"10.1016\/j.bpobgyn.2008.10.005_bib48","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/01.pgp.0000164598.26969.c3","article-title":"Prevalence of underlying adenocarcinoma in women with atypical endometrial hyperplasia","volume":"24","author":"Shutter","year":"2005","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.bpobgyn.2008.10.005_bib49","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/1097-0142(19850715)56:2<403::AID-CNCR2820560233>3.0.CO;2-X","article-title":"The behaviour of endometrial hyperplasia. A long term study of \u201cuntreated\u201d hyperplasia in 170 patients","volume":"56","author":"Kurman","year":"1985","journal-title":"Cancer"},{"key":"10.1016\/j.bpobgyn.2008.10.005_bib50","first-page":"362","article-title":"Progestin therapy in endometrial hyperplasia","volume":"2","author":"Wentz","year":"1974","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2008.10.005_bib51","first-page":"370","article-title":"Precursors of endometrial cancer","volume":"14","author":"Sherman","year":"1978","journal-title":"Isr J Med Sci"},{"key":"10.1016\/j.bpobgyn.2008.10.005_bib52","first-page":"725","article-title":"Preinvasive lesions of the endometrium","volume":"13","author":"Norris","year":"1986","journal-title":"Clin Obstet Gynaecol"},{"key":"10.1016\/j.bpobgyn.2008.10.005_bib53","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/S0140-6736(05)66455-0","article-title":"Endometrial cancer and hormone replacement therapy in the Million Women Study","volume":"365","author":"Million Women Study Collaborators","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.bpobgyn.2008.10.005_bib54","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1093\/ajcn\/45.1.277","article-title":"Adipose tissue as a source of hormones","volume":"45","author":"Siiteri","year":"1987","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.bpobgyn.2008.10.005_bib55","first-page":"16","article-title":"Regulation of estrogen\/progestogen receptors in the endometrium","volume":"41","author":"Caspar","year":"1996","journal-title":"Int J Fertil Menopausal Studies"},{"key":"10.1016\/j.bpobgyn.2008.10.005_bib56","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1136\/bmj.280.6217.822","article-title":"Endometrial disease after treatment with estrogens and progestogens in the climacteric","volume":"280","author":"Paterson","year":"1980","journal-title":"BMJ"},{"key":"10.1016\/j.bpobgyn.2008.10.005_bib57","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3109\/00016347709156348","article-title":"The effects of cyclical estrogen therapy and sequential estrogen therapy on the endometrium of postmenopausal women","volume":"65","author":"Whitehead","year":"1977","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.bpobgyn.2008.10.005_bib58","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1136\/bmj.1.6127.1575","article-title":"Relations between bleeding pattern, endometrial histology and estrogen treatment in postmenopausal women","volume":"1","author":"Sturdee","year":"1978","journal-title":"BMJ"},{"key":"10.1016\/j.bpobgyn.2008.10.005_bib59","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1111\/j.1471-0528.2000.tb11654.x","article-title":"The endometrial response to sequential and continuous combined oestrogen-progestogen replacement therapy","volume":"107","author":"Sturdee","year":"2000","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.bpobgyn.2008.10.005_bib60","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1136\/bmj.298.6667.147","article-title":"Risk of endometrial cancer after treatment with estrogens alone or in conjunction with progestogens. Results of a prospective study","volume":"298","author":"Persson","year":"1989","journal-title":"BMJ"},{"key":"10.1016\/j.bpobgyn.2008.10.005_bib61","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/S0140-6736(96)07365-5","article-title":"Risk of endometrial cancer in relation to use of estrogen combined with cyclic progestogen therapy in postmenopausal women","volume":"349","author":"Beresford","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.bpobgyn.2008.10.005_bib62","first-page":"693","article-title":"Cyclic HRT using quarterly progestin","volume":"83","author":"Ettinger","year":"1994","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2008.10.005_bib63","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0378-5122(99)00033-X","article-title":"The Scandinavian Long Cycle Study Group. Adverse endometrial effects during long cycle hormone replacement therapy","volume":"32","author":"Bjarnason","year":"1999","journal-title":"Maturitas"},{"key":"10.1016\/j.bpobgyn.2008.10.005_bib64","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1023\/A:1008934919159","article-title":"Incidence of cancer among women using long versus monthly cyclical HRT, Finland 1994\u20131997","volume":"12","author":"Pukkala","year":"2001","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.bpobgyn.2008.10.005_bib65","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1056\/NEJM198112313052701","article-title":"Effects of estrogens and progestins on the biochemistry and morphology of a postmenopausal endometrium","volume":"305","author":"Whitehead","year":"1981","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bpobgyn.2008.10.005_bib66","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1136\/bmj.325.7358.239","article-title":"Effect on endometrium of long term treatment with continuous combined estrogen\/progestogen replacement therapy: follow up study","volume":"325","author":"Wells","year":"2002","journal-title":"BMJ"},{"key":"10.1016\/j.bpobgyn.2008.10.005_bib67","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1001\/jama.290.13.1739","article-title":"Effects of estrogen plus progestin on gynaecologic cancers and associated diagnostic procedures: the Women's Health Initiative randomised trial","volume":"290","author":"Anderson","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.bpobgyn.2008.10.005_bib68","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1210\/jc.2006-2207","article-title":"Endometrial effects of tibolone","volume":"92","author":"Archer","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.bpobgyn.2008.10.005_bib69","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1056\/NEJM199712043372301","article-title":"Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women","volume":"337","author":"Delmas","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bpobgyn.2008.10.005_bib70","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1046\/j.1471-0528.2003.02252.x","article-title":"A multi-centre randomised trial to compare uterine safety of raloxifene with a continuous combined hormone replacement therapy containing estradiol and norethisterone acetate","volume":"110","author":"Neven","year":"2003","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.bpobgyn.2008.10.005_bib71","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1080\/13697130008500114","article-title":"Intrauterine application of progestins in hormone replacement therapy","volume":"3","author":"Riphagen","year":"2000","journal-title":"Climacteric"},{"key":"10.1016\/j.bpobgyn.2008.10.005_bib72","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1080\/13697130701852390","article-title":"on behalf of the CHOICE study investigators. Ultra-low-dose continuous combined estradiol and norethisterone acetate: improved reading profile in postmenopausal women","volume":"11","author":"Sturdee","year":"2008","journal-title":"Climacteric"},{"key":"10.1016\/j.bpobgyn.2008.10.005_bib73","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/0029-7844(94)00383-O","article-title":"Hormone replacement therapy and endometrial cancer risk: a meta-analysis","volume":"85","author":"Grady","year":"1995","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2008.10.005_bib74","first-page":"191","article-title":"Use of HRT and the subsequent risk of cancer","volume":"4","author":"Beral","year":"1999","journal-title":"J Epidemiol Biostat"},{"key":"10.1016\/j.bpobgyn.2008.10.005_bib75","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/j.1471-0528.1982.tb04722.x","article-title":"Effects of the climacteric and sequential mestronol and norethisterone on the cervix and genital tract","volume":"89","author":"Paterson","year":"1982","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.bpobgyn.2008.10.005_bib76","article-title":"Monograph on the evaluation of carcogenic risk to humans","volume":"vol. 91","author":"International Agency for Research into Cancer","year":"2008"},{"key":"10.1016\/j.bpobgyn.2008.10.005_bib77","series-title":"The cervix","first-page":"128","article-title":"The effects of oral contraceptive steroids, menopausal hormone replacement therapy on the cervical epithelium","author":"Tay","year":"2006"},{"key":"10.1016\/j.bpobgyn.2008.10.005_bib78","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1016\/S0140-6736(07)61684-5","article-title":"Cervical cancer and hormonal contraceptives: collaborative re-analysis of individual data for 16,573 women with cervical cancer and 35,509 women without cervical cancer from 24 epidemiological studies","volume":"370","author":"Appleby","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.bpobgyn.2008.10.005_bib79","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/ije\/19.1.4","article-title":"Oral contraceptive use and risk of invasive cervical cancer","volume":"19","author":"Brinton","year":"1990","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.bpobgyn.2008.10.005_bib80","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1111\/j.1471-0528.1987.tb03166.x","article-title":"Long term surveillance of mortality and cancer incidents in women receiving hormone replacement therapy","volume":"94","author":"Hunt","year":"1987","journal-title":"Br J Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2008.10.005_bib81","series-title":"Hormones and cancer","first-page":"55","article-title":"Hormones and ovarian cancer","author":"Leake","year":"1999"},{"key":"10.1016\/j.bpobgyn.2008.10.005_bib82","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1093\/oxfordjournals.aje.a116427","article-title":"Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-controlled studies","volume":"136","author":"Whittemore","year":"1992","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.bpobgyn.2008.10.005_bib83","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1016\/0277-5379(89)90375-1","article-title":"Reproductive factors and cancer of the breast, ovary and endometrium","volume":"25","author":"Franceschi","year":"1989","journal-title":"Eur J Cancer Clin Oncol"},{"key":"10.1016\/j.bpobgyn.2008.10.005_bib84","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/ijc.2910490110","article-title":"Pulled analysis of three European case-controlled studies; re-productive factors and risks of ovarian cancer","volume":"49","author":"Negri","year":"1991","journal-title":"Int J Cancer"},{"key":"10.1016\/j.bpobgyn.2008.10.005_bib85","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1002\/ijc.2910490111","article-title":"Pulled analysis of three European case-controlled studies of ovarian cancer. Age at menarche and at menopause","volume":"49","author":"Franceschi","year":"1991","journal-title":"Int J Cancer"},{"key":"10.1016\/j.bpobgyn.2008.10.005_bib86","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1038\/bjc.1995.260","article-title":"Endometrial and ovarian cancer and oral contraceptives \u2013 findings in a large cohort study","volume":"71","author":"Vessey","year":"1995","journal-title":"Br J Cancer"},{"key":"10.1016\/j.bpobgyn.2008.10.005_bib87","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1136\/bmj.39289.649410.55","article-title":"Cancer risk among users of oral contraceptives: cohort data from the Royal College of General Practitioners Oral Contraception Study","volume":"335","author":"Hannaford","year":"2007","journal-title":"BMJ"},{"key":"10.1016\/j.bpobgyn.2008.10.005_bib88","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1093\/oxfordjournals.aje.a117518","article-title":"Estrogen replacement therapy and fatal ovarian cancer","volume":"141","author":"Rodriguez","year":"1995","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.bpobgyn.2008.10.005_bib89","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1001\/jama.285.11.1460","article-title":"Estrogen replacement therapy and ovarian cancer mortality in a large prospective study of US women","volume":"285","author":"Rodriguez","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.bpobgyn.2008.10.005_bib90","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1016\/S0140-6736(07)60534-0","article-title":"Ovarian cancer and hormone replacement therapy in the Million Women study","volume":"369","author":"Million Women Study Collaborators","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.bpobgyn.2008.10.005_bib91","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1093\/aje\/kwf048","article-title":"Risk factors for invasive epithelial ovarian cancer: results from a Swedish case controlled study","volume":"156","author":"Riman","year":"2002","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.bpobgyn.2008.10.005_bib92","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1093\/jnci\/djj375","article-title":"Menopausal hormone therapy and ovarian cancer risk in the National Institutes of Health\u2013AARP Diet and Health Study cohort","volume":"98","author":"Lacey","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.bpobgyn.2008.10.005_bib93","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1158\/1055-9965.EPI-07-0550","article-title":"Menopausal hormone therapy and risk of epithelial ovarian cancer","volume":"16","author":"Rossing","year":"2007","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.bpobgyn.2008.10.005_bib94","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1136\/bmj.321.7264.805","article-title":"ABC of colorectal cancer: clinical review","volume":"321","author":"Boyle","year":"2000","journal-title":"BMJ"},{"key":"10.1016\/j.bpobgyn.2008.10.005_bib95","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1056\/NEJM199012133232404","article-title":"Relation of meat, fat, and fibre intake to the risk of colon cancer in a prospective study among women","volume":"322","author":"Willett","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bpobgyn.2008.10.005_bib96","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/BF00051301","article-title":"Physical activity, obesity and risk of colorectal cancer in women (United States)","volume":"7","author":"Giovannucci","year":"1996","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.bpobgyn.2008.10.005_bib97","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/cmt.5.1.3.14","article-title":"Estrogen and colon cancer; current issues","volume":"5","author":"Al-Azzawi","year":"2002","journal-title":"Climacteric"},{"key":"10.1016\/j.bpobgyn.2008.10.005_bib98","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1056\/NEJMoa032071","article-title":"The WHI Steering Committee. Estrogen plus progestin and colorectal cancer in postmenopausal women","volume":"350","author":"Chlebowski","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bpobgyn.2008.10.005_bib99","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1001\/jama.288.1.58","article-title":"Non-cardiovascular disease outcomes during 6.8 years of hormone therapy: heart and estrogen\/progestin replacement study follow up (HERS II)","volume":"288","author":"Hulley","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.bpobgyn.2008.10.005_bib100","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1001\/jama.293.3.330","article-title":"Effect of estrogen therapy on gall bladder disease","volume":"293","author":"Cirillo","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.bpobgyn.2008.10.005_bib101","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/ijc.10411","article-title":"Post-menopausal hormonal therapy and gallbladder cancer risk","volume":"99","author":"Gallus","year":"2002","journal-title":"Int J Cancer"},{"key":"10.1016\/j.bpobgyn.2008.10.005_bib102","first-page":"337","article-title":"Gallbladder disease and use of transdermal versus oral replacement therapy in postmenopausal women: prospective cohort study","author":"Liu","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.bpobgyn.2008.10.005_bib103","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1093\/ije\/27.5.751","article-title":"Hormonal and reproductive influences and risk of melanoma in women","volume":"27","author":"Smith","year":"1998","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.bpobgyn.2008.10.005_bib104","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1158\/1078-0432.CCR-0911-3","article-title":"Hormone replacement therapy and lung cancer risk: a case-control analysis","volume":"10","author":"Schabatch","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.bpobgyn.2008.10.005_bib105","doi-asserted-by":"crossref","first-page":"5785","DOI":"10.1200\/JCO.2007.13.3975","article-title":"Reproductive factors, hormone use, estrogen receptor expression and risk of non small-cell lung cancer in women","volume":"25","author":"Schwartz","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bpobgyn.2008.10.005_bib106","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1158\/1055-9965.EPI-07-2683","article-title":"Postmenopausal hormone therapy and lung cancer risk in the cancer prevention study II nutrition cohort","volume":"17","author":"Rodriguez","year":"2008","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.bpobgyn.2008.10.005_bib107","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1002\/cncr.22987","article-title":"Hormone replacement therapy and lung cancer risk in Chinese","volume":"110","author":"Chen","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.bpobgyn.2008.10.005_bib108","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1200\/JCO.2005.02.9827","article-title":"Hormone replacement therapy is associated with decreased survival in women with lung cancer","volume":"24","author":"Ganti","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bpobgyn.2008.10.005_bib109","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/sj.bjc.6602906","article-title":"Hormone replacement therapy and risks of oesophageal and gastric adenocarcinoma","volume":"94","author":"Lindblad","year":"2006","journal-title":"Br J Cancer"}],"container-title":["Best Practice &amp; Research Clinical Obstetrics &amp; Gynaecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521693408001442?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521693408001442?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,3,4]],"date-time":"2024-03-04T03:13:51Z","timestamp":1709522031000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521693408001442"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2]]},"references-count":107,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,2]]}},"alternative-id":["S1521693408001442"],"URL":"https:\/\/doi.org\/10.1016\/j.bpobgyn.2008.10.005","relation":{},"ISSN":["1521-6934"],"issn-type":[{"value":"1521-6934","type":"print"}],"subject":[],"published":{"date-parts":[[2009,2]]}}}